Skip to main content

YAP1 Uses Its Modular Protein Domains and Conserved Sequence Motifs to Orchestrate Diverse Repertoires of Signaling

  • Chapter
  • First Online:

Abstract

Yes-associated protein 1 (YAP1) is a potent oncogenic protein and is one of the two main effectors of the Hippo tumor suppressor pathway. Originally, YAP1 cDNA was isolated by screening expression libraries for proteins that associate with SH3 domains of Yes and Src protein-tyrosine kinases. Subsequently, YAP1 was shown by homology searches or functional assays to encode multiple protein–protein binding modules including a WW domain, a PDZ domain-binding motif, and TEAD-interaction domain (TID) as well as a transcriptional activation domain (TAD). The TID region encodes a major regulatory phosphorylation site, Serine 127, which plays a critical role in regulating the subcellular localization of YAP1. The TAD region contains a putative coiled-coil region, whose function is unknown, and a tyrosine phosphorylation site that is the subject of intense study. Through reductionistic approaches of molecular and cellular biology, we have gained insight into the detailed function of most of the individual domains, motifs, and selected phosphorylation sites of YAP1. Here, we review how these YAP1 domains act in concert to regulate cell contact inhibition as well as a balance between cell proliferation and apoptosis. Given the mounting evidence that many parameters of malignant cancer progression are driven by Hippo-regulated pathways, understanding the details of how YAP1 regulates signaling is of paramount importance in designing effective strategies to control the oncogenic function of YAP1.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell. 2009;139:757–69.

    Article  PubMed  CAS  Google Scholar 

  • Anbanandam A, Albarado DC, Nguyen CT, Halder G, Gao X, et al. Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain. Proc Natl Acad Sci U S A. 2006;103:17225–30.

    Article  PubMed  CAS  Google Scholar 

  • Andre B, Springael JY. WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding Yes-associated protein YAP65. Biochem Biophys Res Commun. 1994;205:1201–5.

    Article  PubMed  CAS  Google Scholar 

  • Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, et al. A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev. 2011;25:1275–88.

    Article  PubMed  CAS  Google Scholar 

  • Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, et al. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 2006;20:2687–700.

    Article  PubMed  CAS  Google Scholar 

  • Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, et al. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev. 2010;24:2420–9.

    Article  PubMed  CAS  Google Scholar 

  • Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol. 2003;160:423–32.

    Article  PubMed  CAS  Google Scholar 

  • Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73 mediated apoptosis. Mol Cell. 2003;11:11–23.

    Article  PubMed  CAS  Google Scholar 

  • Bork P, Sudol M. The WW domain: a signalling site in dystrophin? Trends Biochem Sci. 1994;19:531–3.

    Article  PubMed  CAS  Google Scholar 

  • Bottomly D, Kyler SL, McWeeney SK, Yochum GS. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 2010;38:5735–45.

    Article  PubMed  CAS  Google Scholar 

  • Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, et al. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem. 2011;286:7018–26.

    Article  PubMed  CAS  Google Scholar 

  • Chen HI, Einbond A, Kwak SJ, Linn H, Koepf E, et al. Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J Biol Chem. 1997;272:17070–7.

    Article  PubMed  CAS  Google Scholar 

  • Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A. 1995;92:7819–23.

    Article  PubMed  CAS  Google Scholar 

  • Chen L, Loh PG, Song H. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway. Protein Cell. 2010;1:1073–83.

    Article  PubMed  CAS  Google Scholar 

  • Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–205.

    Article  PubMed  CAS  Google Scholar 

  • Danovi SA, Rossi M, Gudmundsdottir K, Yuan M, Melino G, et al. Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ. 2008;15:217–9.

    Article  PubMed  CAS  Google Scholar 

  • Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–83.

    Article  PubMed  CAS  Google Scholar 

  • Einbond A, Sudol M. Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett. 1996;384:1–8.

    Article  PubMed  CAS  Google Scholar 

  • Enamoto M, Igaki T. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways. J Genet Genomics. 2011;38:461–70.

    Article  Google Scholar 

  • Espanel X, Sudol M. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem. 2001;276:14514–23.

    PubMed  CAS  Google Scholar 

  • Ferrigno O, Lallemand F, Verrecchia F, L’Hoste S, Camonis J, et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene. 2002;21:4879–84.

    Article  PubMed  CAS  Google Scholar 

  • Gao B, Lee SM, Fang D. The tyrosine kinase c-Abl protects c-Jun from ubiquitination-mediated degradation in T cells. J Biol Chem. 2006;281:29711–8.

    Article  PubMed  CAS  Google Scholar 

  • Guo C, Tommasi S, Liu L, Yee JK, Dammann R, et al. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol. 2007;17:700–5.

    Article  PubMed  CAS  Google Scholar 

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

    Article  PubMed  CAS  Google Scholar 

  • Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem. 2008;283:5496–509.

    Article  PubMed  CAS  Google Scholar 

  • Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332: 458–61.

    Article  PubMed  CAS  Google Scholar 

  • Hofmann K, Bucher P. The rsp5-domain is shared by proteins of diverse functions. FEBS Lett. 1995;358:153–7.

    Article  PubMed  CAS  Google Scholar 

  • Hong W, Guan KL. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol. 2012;23:785–93.

    Article  PubMed  CAS  Google Scholar 

  • Hu YF, Li R. JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. Genes Dev. 2002;16:1509–17.

    Article  PubMed  CAS  Google Scholar 

  • Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, et al. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene. 2012. Jun 11 [Epub ahead of print]

    Google Scholar 

  • Imajo M, Miyyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signaling to the inhibition of Wnt/beta-catenin signaling. EMBO J. 2012;31:1109–22.

    Article  PubMed  CAS  Google Scholar 

  • Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000;19:6778–91.

    Article  PubMed  CAS  Google Scholar 

  • Komuro A, Nagai M, Navin NE, Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem. 2003;278:33334–41.

    Article  PubMed  CAS  Google Scholar 

  • Konsavage Jr WM, Kyler SL, Rennoll SA, Jin G, Yochum GS. Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem. 2012;287:11730–9.

    Article  PubMed  CAS  Google Scholar 

  • Kremerskothen J, Plaas C, Buther K, Finger I, Veltel S, et al. Characterization of KIBRA, a novel WW domain-containing protein. Biochem Biophys Res Commun. 2003;300:862–7.

    Article  PubMed  CAS  Google Scholar 

  • Lai D, Ho KC, Hao Y, Yang X. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 2011;71:2728–38.

    Article  PubMed  CAS  Google Scholar 

  • Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell. 2008;29:350–61.

    Article  PubMed  CAS  Google Scholar 

  • Li Z, Zhao B, Wang P, Chen F, Dong Z, et al. Structural insights into the YAP and TEAD complex. Genes Dev. 2010;24:235–40.

    Article  PubMed  CAS  Google Scholar 

  • Lim SK, Orhant-Prioux M, Toy W, Tan KY, Lim YP. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor alpha function in breast cancer via the Wnt pathway. FASEB J. 2011;9:3004–18.

    Article  Google Scholar 

  • Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun. 2010;394:623–7.

    Article  PubMed  CAS  Google Scholar 

  • Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, et al. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene. 2012;Apr 23. Epub ahead of print.

    Google Scholar 

  • Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300–5.

    Article  PubMed  CAS  Google Scholar 

  • Macias MJ, Hyvonen M, Baraldi E, Schultz J, Sudol M, et al. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature. 1996;382:646–9.

    Article  PubMed  CAS  Google Scholar 

  • Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–91.

    Article  PubMed  CAS  Google Scholar 

  • Mauviel A, Nallet-Staub F, Varelas X. Integrating developmental signals: a Hippo in the (path)way. Oncogene. 2012;31:1743–56.

    Article  PubMed  CAS  Google Scholar 

  • McCaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol. 2011;21:727–35.

    Article  PubMed  CAS  Google Scholar 

  • Mihlan S, Reiss C, Thalheimer P, Herterich S, Gaetzner S, et al. Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions. Oncogene. 2012. Jun 4 [Epub ahead of print]

    Google Scholar 

  • Mohler PJ, Kreda SM, Boucher RC, Sudol M, Stutts MJ, et al. Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50. J Cell Biol. 1999;147:879–90.

    Article  PubMed  CAS  Google Scholar 

  • Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis. 2011;32:389–98.

    Article  PubMed  CAS  Google Scholar 

  • Ogata M, Takada T, Mori Y, Oh-hora M, Uchida Y, et al. Effects of overexpression of PTP36, a putative protein tyrosine phosphatase, on cell adhesion, cell growth, and cytoskeletons in HeLa cells. J Biol Chem. 1999a;274:12905–9.

    Article  PubMed  CAS  Google Scholar 

  • Ogata M, Takada T, Mori Y, Uchida Y, Miki T, et al. Regulation of phosphorylation level and distribution of PTP36, a putative protein tyrosine phosphatase, by cell-substrate adhesion. J Biol Chem. 1999b;274:20717–24.

    Article  PubMed  CAS  Google Scholar 

  • Oka T, Mazack V, Sudol M. Mst2 and Lats kinases regulate apoptotic function of YAP. J Biol Chem. 2008;283:27534–46.

    Article  PubMed  CAS  Google Scholar 

  • Oka T, Sudol M. Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells. 2009;14:607–15.

    Article  PubMed  CAS  Google Scholar 

  • Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D, et al. Functional complex between YAP2 and ZO-2 is PDZ domain dependent, regulates YAP2 nuclear localization and signaling. Biochem J. 2010;432:461–72.

    Article  PubMed  CAS  Google Scholar 

  • Oka T, Schmitt AP, Sudol M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene. 2012;31:128–34.

    Article  PubMed  CAS  Google Scholar 

  • Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491–505.

    Article  PubMed  CAS  Google Scholar 

  • Paramasivam M, Sarkeshik A, Yates 3rd JR, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725–33.

    Article  PubMed  CAS  Google Scholar 

  • Pawson T. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell. 2004;116:191–203.

    Article  PubMed  CAS  Google Scholar 

  • Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol. 2012;22:389–96.

    Article  PubMed  CAS  Google Scholar 

  • Ren R, Mayer BJ, Cicchetti P, Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 1993;259:1157–61.

    Article  PubMed  CAS  Google Scholar 

  • Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell. 2011;144:782–95.

    Article  PubMed  CAS  Google Scholar 

  • Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, et al. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal. 2011;4:ra33.

    Article  PubMed  Google Scholar 

  • Skouloudaki K, Walz G. YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation. PLoS One. 2012;7:e35735.

    Article  PubMed  CAS  Google Scholar 

  • Smith AL, Mitchell PJ, Shipley J, Gusterson BA, Rogers MV, et al. Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains. Biochem Biophys Res Commun. 1995;209:959–65.

    Article  PubMed  CAS  Google Scholar 

  • Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem. 2001;276:15164–73.

    Article  PubMed  CAS  Google Scholar 

  • Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene. 1994;9:2145–52.

    PubMed  CAS  Google Scholar 

  • Sudol M, Bork P, Einbond A, Kastury K, Druck T, et al. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem. 1995;270:14733–41.

    Article  PubMed  CAS  Google Scholar 

  • Sudol M. WW domain. In: Cesareni G, Gimona M, Sudol M, Yaffe M, editors. Modular protein domains. Weinheim: Wiley VCH, Verlag Gmbh & Co; 2004. p. 59–72.

    Google Scholar 

  • Sudol M, Harvey KF. Modularity in the Hippo signaling pathway. Trends Biochem Sci. 2010;35:627–33.

    Article  PubMed  CAS  Google Scholar 

  • Sudol M, Shields DC, Farooq A. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Semin Cell Dev Biol. 2012;23:827–33.

    Article  PubMed  CAS  Google Scholar 

  • Tamm C, Bower N, Anneren C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci. 2011;124:1136–44.

    Article  PubMed  Google Scholar 

  • Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, et al. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol. 2006;8:1291–7.

    Article  PubMed  CAS  Google Scholar 

  • Tian W, Yu J, Tomchick DR, Pan D, Luo X. Structural and functional analysis of the YAP-binding domain of human TEAD2. Proc Natl Acad Sci U S A. 2010;107:7293–8.

    Article  PubMed  CAS  Google Scholar 

  • Valis K, Prochazka L, Boura E, Chladova J, Obsil T, et al. Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner. Cancer Res. 2011;71:946–54.

    Article  PubMed  CAS  Google Scholar 

  • Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell. 2010;19:831–44.

    Article  PubMed  CAS  Google Scholar 

  • Varelas X, Wrana JL. Coordinating developmental signaling: novel roles for the Hippo pathway. Trends Cell Biol. 2012;22:88–96.

    Article  PubMed  CAS  Google Scholar 

  • Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev. 2001;15:1229–41.

    Article  PubMed  CAS  Google Scholar 

  • Wadham C, Gamble JR, Vadas MA, Khew-Goodall Y. Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation. J Cell Sci. 2000;113(Pt 17):3117–23.

    PubMed  CAS  Google Scholar 

  • Wadham C, Gamble JR, Vadas MA, Khew-Goodall Y. The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. Mol Biol Cell. 2003;14:2520–9.

    Article  PubMed  CAS  Google Scholar 

  • Wang S, Raab RW, Schatz PJ, Guggino WB, Li M. Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett. 1998;427:103–8.

    Article  PubMed  CAS  Google Scholar 

  • Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem. 2011;286:4364–70.

    Article  PubMed  CAS  Google Scholar 

  • Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, et al. Mutational analysis of the tyrosine ­phosphatome in colorectal cancers. Science. 2004;304:1164–6.

    Article  PubMed  CAS  Google Scholar 

  • Wyatt L, Khew-Goodall Y. PTP-Pez: a novel regulator of TGFbeta signaling. Cell Cycle. 2008;7:2290–5.

    PubMed  CAS  Google Scholar 

  • Xu Y, Stamenkovic I, Yu Q. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res. 2010;70:2455–64.

    Article  PubMed  CAS  Google Scholar 

  • Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 1999;18:2551–62.

    Article  PubMed  CAS  Google Scholar 

  • Yang X, Yu K, Hao Y, Li DM, Stewart R, et al. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat Cell Biol. 2004;6:609–17.

    Article  PubMed  CAS  Google Scholar 

  • Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 2004;23:790–9.

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Ren F, Zhang Q, Chen Y, Wang B, et al. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell. 2008;14:377–87.

    Article  PubMed  CAS  Google Scholar 

  • Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63.

    Article  PubMed  Google Scholar 

  • Zhao B, Kim J, Ye X, Lai ZC, Guan KL. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res. 2009;69:1089–98.

    Article  PubMed  CAS  Google Scholar 

  • Zhou D, Zhang Y, Wu H, Barry E, Yin Y, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 2011;108:E1312–20.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank our colleagues Virginia Mazack and Wannian Yang for valuable comments on the first version of the manuscript and Gregory Yochum for valuable discussions, comments, and for sharing his unpublished data. This work was supported by PA Breast Cancer Coalition Grants (#60707 an #920093) plus the Geisinger Clinic (to MS), by funds from the National Institutes of Health (Grants# R01-CA94108 and P30-CA016056) and the Department of Defense (PC074228, PC101210) (to IHG), and by Roswell Park Cancer Institute and NCI grant #P30 CA016056 (to JZ).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marius Sudol Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sudol, M., Gelman, I.H., Zhang, J. (2013). YAP1 Uses Its Modular Protein Domains and Conserved Sequence Motifs to Orchestrate Diverse Repertoires of Signaling. In: Oren, M., Aylon, Y. (eds) The Hippo Signaling Pathway and Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6220-0_4

Download citation

Publish with us

Policies and ethics